HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Liu Selected Research

alpha(2-8)-N-propionylpolysialic acid

10/2000Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Liu Research Topics

Disease

75Neoplasms (Cancer)
01/2022 - 01/2000
14Infections
09/2021 - 05/2000
14Neoplasm Metastasis (Metastasis)
01/2021 - 05/2000
10Lung Neoplasms (Lung Cancer)
01/2021 - 02/2000
9Stomach Neoplasms (Stomach Cancer)
06/2018 - 12/2000
9Carcinoma (Carcinomatosis)
07/2014 - 05/2000
8Inflammation (Inflammations)
01/2021 - 10/2012
8Breast Neoplasms (Breast Cancer)
10/2017 - 08/2005
8Neuroblastoma
06/2014 - 06/2000
7Pain (Aches)
10/2018 - 06/2013
7Pancreatic Neoplasms (Pancreatic Cancer)
02/2016 - 04/2000
7Carcinogenesis
01/2016 - 10/2001
7Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2001 - 08/2000
6Hypertension (High Blood Pressure)
01/2022 - 08/2007
6Myocardial Infarction
09/2021 - 06/2000
6Necrosis
01/2021 - 03/2006
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 06/2012
6Hepatocellular Carcinoma (Hepatoma)
12/2019 - 03/2012
5Heart Failure
05/2021 - 08/2000
5Cardiovascular Diseases (Cardiovascular Disease)
05/2021 - 08/2000
5Allergic Rhinitis
11/2018 - 01/2011
5Leukemia
04/2015 - 06/2000
5Melanoma (Melanoma, Malignant)
06/2013 - 11/2006
4Hemorrhage
01/2022 - 10/2018
4Type 2 Diabetes Mellitus (MODY)
10/2021 - 01/2012
4Prostatic Neoplasms (Prostate Cancer)
12/2016 - 05/2000
4Hyperalgesia
05/2015 - 01/2000
4AIDS-Related Complex (ARC)
06/2012 - 06/2012
4Chest Pain (Chest Pains)
02/2001 - 02/2000
3Rectal Neoplasms (Rectal Cancer)
06/2022 - 12/2020
3Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2000
3Hyperplasia
01/2021 - 05/2000
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 04/2000
3Sarcoma (Soft Tissue Sarcoma)
09/2020 - 06/2013
3Adenocarcinoma
01/2020 - 12/2000
3Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 01/2000
3Pathologic Constriction (Stenosis)
10/2018 - 10/2016
3Wounds and Injuries (Trauma)
08/2018 - 10/2011
3Body Weight (Weight, Body)
04/2018 - 01/2012
3Nasopharyngeal Carcinoma
07/2016 - 08/2012
3Fibrosis (Cirrhosis)
01/2015 - 10/2011
3Ventricular Fibrillation
09/2014 - 08/2000
3Lymphatic Metastasis
03/2008 - 02/2000
2Cataract (Cataracts)
11/2022 - 07/2021
2Adenoma (Adenomas)
01/2022 - 12/2000
2Proteinuria
01/2022 - 10/2018
2Esophageal Squamous Cell Carcinoma
01/2022 - 08/2013
2Pancreatitis
10/2021 - 08/2017
2Insulin Resistance
10/2021 - 05/2010
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2021 - 05/2021
2Rupture
07/2021 - 06/2013

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2000
9Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2013
9Prion ProteinsIBA
06/2003 - 08/2000
8Messenger RNA (mRNA)IBA
09/2019 - 02/2000
7CytokinesIBA
01/2021 - 03/2001
6Pharmaceutical PreparationsIBA
05/2021 - 01/2012
6Biological ProductsIBA
06/2020 - 03/2006
6Small Interfering RNA (siRNA)IBA
05/2015 - 03/2008
5AntioxidantsIBA
12/2021 - 08/2000
5Histone Deacetylases (Histone Deacetylase)IBA
12/2021 - 11/2010
5Estrogen ReceptorsIBA
09/2019 - 01/2014
5Telomerase (Telomerase Reverse Transcriptase)IBA
10/2014 - 10/2000
5EnzymesIBA
09/2014 - 06/2000
5ParaffinIBA
10/2011 - 04/2000
4Blood Glucose (Blood Sugar)IBA
10/2021 - 01/2012
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
12/2019 - 08/2001
4Long Noncoding RNAIBA
08/2019 - 05/2017
4AntigensIBA
07/2018 - 03/2001
4Peptide Hydrolases (Proteases)FDA Link
10/2017 - 05/2001
4Glucose (Dextrose)FDA LinkGeneric
05/2017 - 05/2010
4IronIBA
10/2016 - 01/2013
4MicroRNAs (MicroRNA)IBA
07/2015 - 04/2010
4Oncogene Proteins (Oncogene Protein)IBA
06/2014 - 11/2010
4ChemokinesIBA
08/2008 - 08/2000
4Chemokine CCL5IBA
11/2007 - 08/2000
4Protein Isoforms (Isoforms)IBA
06/2003 - 08/2000
3Insulin (Novolin)FDA Link
05/2021 - 05/2010
3InterleukinsIBA
01/2021 - 10/2012
3Immunoglobulin G (IgG)IBA
03/2020 - 12/2000
3Oxygen (Dioxygen)IBA
01/2020 - 02/2013
3Minocycline (Cyclops)FDA LinkGeneric
10/2018 - 04/2016
3Indicators and Reagents (Reagents)IBA
09/2014 - 08/2000
3Caspase 3 (Caspase-3)IBA
06/2013 - 02/2002
3Monoclonal AntibodiesIBA
06/2003 - 10/2000
3MetalsIBA
11/2001 - 08/2000
2VemurafenibIBA
09/2021 - 06/2013
2Capsules (Microcapsules)IBA
07/2021 - 12/2000

Therapy/Procedure

26Therapeutics
01/2022 - 01/2000
18Radiotherapy
02/2021 - 07/2001
12Drug Therapy (Chemotherapy)
01/2022 - 02/2002
5Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2016 - 03/2012
3Length of Stay
10/2021 - 08/2017
3Immunotherapy
09/2020 - 10/2000
3Conformal Radiotherapy
02/2016 - 03/2012
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2001 - 08/2000
2Operative Time
10/2021 - 05/2019
2Lymph Node Excision (Lymph Node Dissection)
10/2021 - 01/2014
2Intravenous Injections
09/2021 - 05/2000